Cleared Special

ART-Plan (K230023) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K230023 · Therapanacea Sas · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
105d
Days
Class 2
Risk

K230023 is an FDA 510(k) clearance for the ART-Plan. Classified as Radiological Image Processing Software For Radiation Therapy (product code QKB), Class II - Special Controls.

Submitted by Therapanacea Sas (Paris, FR). The FDA issued a Cleared decision on April 19, 2023 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Therapanacea Sas devices

Submission Details

510(k) Number K230023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 04, 2023
Decision Date April 19, 2023
Days to Decision 105 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 107d · This submission: 105d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QKB Radiological Image Processing Software For Radiation Therapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Semi-automatic Or Fully-automated Radiological Image Processing And Analysis Tools For Radiation Therapy. Software Implementing Artificial Intelligence (ai) Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Radiological Images. In These Devices, The Algorithm Training Images Typically Impact Device Performance. Ai Based Radiological Image Processing Software Is Intended To Be Used In The Workflow Of Radiation Therapy. Adaptive Ai Algorithms Are Not Within The Scope Of This Product Code. Primary Radiation Dose Calculation Or Plan Optimization For Treatment Planning Are Not Within Scope Of This Product Code.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - QKB Radiological Image Processing Software For Radiation Therapy

All 45
Devices cleared under the same product code (QKB) and FDA review panel - the closest regulatory comparables to K230023.
Contour ProtégéAI
K231765 · Mim Software, Inc. · Nov 2023
EFAI RTSUITE CT HCAP-Segmentation System
K231928 · Ever Fortune.Ai, Co., Ltd. · Sep 2023
Auto Segmentation
K230082 · Ge Medical Systems, LLC · May 2023
AutoContour Model RADAC V3
K230685 · Radformation, Inc. · Apr 2023
Contour ProtégéAI
K223774 · Mim Software, Inc. · Apr 2023
AccuContour
K221706 · Manteia Technologies Co., Ltd. · Mar 2023